AI tool to help doctors read gastric cancer imaging
Part of Cancer, Digestive system clinical trials.
This study tests whether an AI-assisted tool helps radiologists (doctors who read imaging scans) better interpret CT scans of gastric cancer patients. The research compares how accurately doctors read scans with and without AI help.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had gastric cancer surgery with confirmed pathology results showing the cancer stage (T1–T4)
- Your CT scan images from Liaoning Cancer Hospital must be complete, clear, and free of major technical problems
- You must have complete medical and pathology records available for comparison
- If you are a radiologist, you must be licensed and willing to review images both with and without AI assistance
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an AI tool can help doctors read CT scans of the liver to find cancerous spots. If you have had a CT scan of your abdomen with specific timing, you might be able to join.
This trial uses artificial intelligence to analyze contrast-enhanced CT scans of patients with gastric cancer. It aims to improve how doctors detect and stage the disease, which may lead to better treatment decisions.
This trial tests whether an AI tool helps pathologists read your tissue samples more accurately. It's a study for people who have had a stomach biopsy or gastric cancer surgery, where digital images of the tissue are available.
This study tests whether an AI assistant can help radiologists (doctors who read X-rays and scans) interpret chest CT scans more accurately. Radiologists will use the AI tool and provide feedback on whether it's helpful.
This study tests an artificial intelligence tool that analyzes images taken during stomach endoscopy to help diagnose early-stage stomach cancer or precancerous changes. The goal is to improve how doctors identify and treat these lesions early, when treatment is most effective.
This study tests whether an AI tool can predict how well stomach cancer responds to chemotherapy before surgery. It uses CT scans and biopsy images taken before treatment starts to see if the AI can help guide future care.
Hear when a new Gastric Cancer (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.